Company intelligence / Profile preview

ThirdLaw Molecular

Blue Bell, Pennsylvania, USAthirdlawtx.com ↗

Ownership: Private
Employees: ~8
Development stage: Preclinical

Overview

ThirdLaw Molecular has developed a proprietary drug discovery platform based on Spiroligomer™ molecules—synthetic macromolecules designed to combine the best features of small molecules and biologics. The company recently launched a DNA encoded library containing over 4.5 billion unique compounds to enable rapid screening against challenging protein targets. Early focus areas include cancer and inflammatory diseases; initial results have attracted interest from large pharmaceutical partners but no clinical data or IND filings have been reported yet.

Therapeutic areas: OtherOncologyImmunologyInfectious Diseases
Modalities: Spiroligomer™ molecules (novel synthetic macromolecules with properties of both small molecules and biologics)Small molecule-like modalities (cell permeability, oral bioavailability)Biologic-like selectivity
Industry: Biotech

Partnerships

Evaluative partnership with an undisclosed large pharmaceutical company that received a sample library for assessment. No major announced pharma partnerships yet.

Beyond the preview

Go deeper on ThirdLaw Molecular.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ThirdLaw Molecular.

Explore the full profile